Table 2 Characteristic of dietary flavonoid intake between nocturia and non-nocturia.

From: Inverse association between dietary flavonoid intake and nocturia in middle-aged and older adults from NHANES 2007–2010

Characteristic

Overall

N = 5938 (100%)

Non-nocturia

N = 3707 (70%)

Nocturia

N = 2231 (30%)

P-value

Total flavonoids (mg/day)

 Q1 (0.00–26.82)

1485 (22%)

851 (20%)

634 (25%)

0.002

 Q2 (26.82–69.53)

1484 (24%)

947 (25%)

537 (23%)

 Q3 (69.53–250.76)

1484 (25%)

948 (25%)

536 (24%)

 Q4 (250.76–8018.67)

1485 (29%)

961 (30%)

524 (28%)

Isoflavones (mg/day)

 Q1 (0.00–0.00)

1485 (25%)

916 (25%)

569 (25%)

0.072

 Q2 (0.00–0.01)

1484 (25%)

905 (24%)

579 (28%)

 Q3 (0.01–0.06)

1484 (24%)

924 (25%)

560 (23%)

 Q4 (0.06–213.30)

1485 (26%)

962 (27%)

523 (24%)

Flavan-3-ols (mg/day)

 Q1 (0.00–5.47)

1485 (21%)

846 (19%)

639 (26%)

< 0.001

 Q2 (5.47–16.85)

1484 (24%)

948 (25%)

536 (23%)

 Q3 (16.85–187.53)

1484 (25%)

954 (26%)

530 (23%)

 Q4 (166.20–7727.37)

1485 (29%)

959 (30%)

526 (28%)

Anthocyanidins (mg/day)

 Q1 (0.00–0.20)

1485 (24%)

899 (22%)

586 (26%)

< 0.001

 Q2 (0.20–2.35)

1484 (23%)

876 (22%)

608 (25%)

 Q3 (2.35–11.97)

1484 (23%)

930 (23%)

554 (23%)

 Q4 (11.97–1497.90)

1485 (30%)

1,002 (32%)

483 (26%)

Flavanones (mg/day)

 Q1 (0.00–0.07)

1485 (24%)

907 (24%)

578 (24%)

0.537

 Q2 (0.07–0.89)

1484 (26%)

931 (27%)

553 (26%)

 Q3 (0.89–20.72)

1484 (26%)

949 (26%)

535 (25%)

 Q4 (20.72–376.95)

1485 (24%)

920 (24%)

565 (25%)

Flavones (mg/day)

 Q1 (0.00–0.21)

1485 (22%)

853 (20%)

632 (24%)

0.008

 Q2 (0.21–0.55)

1484 (24%)

920 (24%)

564 (25%)

 Q3 (0.55–1.13)

1484 (26%)

943 (26%)

541 (25%)

 Q4 (1.13–87.24)

1485 (28%)

991 (30%)

494 (25%)

Flavonols (mg/day)

 Q1 (0.00–7.16)

1485 (20%)

822 (18%)

663 (25%)

< 0.001

 Q2 (7.16–13.32)

1484 (24%)

947 (24%)

537 (24%)

 

 Q3 (13.32–23.49)

1484 (26%)

968 (27%)

516 (24%)

 

 Q4 (23.49–288.14)

1485 (30%)

970 (31%)

515 (27%)

 
  1. Significant values are given in bold.